Fas (CD95, APO‐1) antigen expression and function in murine liver endothelial cells: implications for the regulation of apoptosis in liver endothelial cells

ABSTRACTThe Fas (CD95, APO‐1) receptor is a membrane‐associated polypeptide that can mediate apoptosis in various cell types. Although Fas receptor is expressed in endothelial cells (EC), little is known about its function in these cells. The expression of Fas by liver endothelial cells (LEC) sugges...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The FASEB journal 1999-11, Vol.13 (14), p.1950-1960
Hauptverfasser: Cardier, Jose E., Schulte, Tara, Kammer, Heide, Kwak, Jenny, Cardier, Marisabel
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1960
container_issue 14
container_start_page 1950
container_title The FASEB journal
container_volume 13
creator Cardier, Jose E.
Schulte, Tara
Kammer, Heide
Kwak, Jenny
Cardier, Marisabel
description ABSTRACTThe Fas (CD95, APO‐1) receptor is a membrane‐associated polypeptide that can mediate apoptosis in various cell types. Although Fas receptor is expressed in endothelial cells (EC), little is known about its function in these cells. The expression of Fas by liver endothelial cells (LEC) suggests that upon stimulation, apoptosis may occur in these cells. We show that Fas is highly and constitutively expressed in cloned murine liver endothelial cells (LEC‐1). In contrast, FasL expression was not detected at the protein and mRNA level in these cells. Our results show that Fas ligation in LEC‐1 induces apoptotic cell death, indicating that Fas receptor is functional in these cells. The doses of Fas agonist required to induce LEC‐1 apoptosis were higher than those used previously in other cells, including hepatocytes, suggesting that LEC‐1 are highly resistant to the Fas apoptotic pathway. TNF treatment of LEC‐1 induced up‐regulation of Fas receptor on these cells. In contrast, TNF did not induce the expression of FasL on LEC‐1. An increased susceptibility to Fas‐mediated apoptosis was observed in TNF‐treated LEC‐1. Enhanced susceptibility to Fas‐mediated apoptosis was also observed in LEC‐1 pretreated with actinomycin D, suggesting that transcription of message coding for protective proteins is necessary to protect these cells against Fas‐mediated apoptosis. Up‐regulation of VCAM‐1 and ICAM‐1 was observed in LEC‐1 treated with a dose of Fas agonist that does not induce apoptosis. To our knowledge, this is the first report that Fas mediates apoptosis in LEC, suggesting that apoptosis of these cells may participate in the liver damage observed in animals after receiving anti‐Fas mAb or soluble FasL. Our findings also suggest that the Fas/FasL system may transduce activating signals independently of cell death in LEC‐1.—Cardier, J. E., Schulte, T., Kammer, H., Kwak, J., Cardier, M. Fas (CD95, APO‐1) antigen expression and function in murine liver endothelial cells: implications for the regulation of apoptosis in liver endothelial cells. FASEB J. 13, 1950–1960 (1999)
doi_str_mv 10.1096/fasebj.13.14.1950
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69235871</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17427496</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4840-bea84beeee5c1cad89ab4149c3599727977e066a4d322150894873f9f3229ebc3</originalsourceid><addsrcrecordid>eNqFkUFu1TAQhi0Eoo_CAdggrxBIzcMTO07M7vXRR4sqFamwtpxkUlw5cWonQHccgRP0cD1Jk6YLNqjeWDP-5rPln5DXwNbAlPzQmIjl5Rr4GsQaVMaekBVknCWykOwpWbFCpYmUvNgjL2K8ZIwBA_mc7AHLhIC8WJGbnYn03faTyg7o5uvZ7Z-_8J6abrAX2FH83QeM0fpuatW0GbtqmAvb0XYMtkPq7E8MFLvaDz_QWeNohc7Fj9S2vbOVmfFIGx_odE4DXozuvkd9Q03v-8FHG2fff0QvybPGuIivHvZ98n139G17nJyefT7Zbk6TShSCJSWaQpQ4rayCytSFMqUAoSqeKZWnucpzZFIaUfM0hWz6F1HkvFHNVCosK75P3i7ePvirEeOgWxvnF5gO_Ri1VCnPihweBSEXaS6UnEBYwCr4GAM2ug-2NeFaA9NzenpJTwPXIPSc3jTz5kE-li3W_0wscU3AZgF-WYfXjxv17vww3W3Ojw6_AAdxf8kd18mtTw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17427496</pqid></control><display><type>article</type><title>Fas (CD95, APO‐1) antigen expression and function in murine liver endothelial cells: implications for the regulation of apoptosis in liver endothelial cells</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Alma/SFX Local Collection</source><creator>Cardier, Jose E. ; Schulte, Tara ; Kammer, Heide ; Kwak, Jenny ; Cardier, Marisabel</creator><creatorcontrib>Cardier, Jose E. ; Schulte, Tara ; Kammer, Heide ; Kwak, Jenny ; Cardier, Marisabel</creatorcontrib><description>ABSTRACTThe Fas (CD95, APO‐1) receptor is a membrane‐associated polypeptide that can mediate apoptosis in various cell types. Although Fas receptor is expressed in endothelial cells (EC), little is known about its function in these cells. The expression of Fas by liver endothelial cells (LEC) suggests that upon stimulation, apoptosis may occur in these cells. We show that Fas is highly and constitutively expressed in cloned murine liver endothelial cells (LEC‐1). In contrast, FasL expression was not detected at the protein and mRNA level in these cells. Our results show that Fas ligation in LEC‐1 induces apoptotic cell death, indicating that Fas receptor is functional in these cells. The doses of Fas agonist required to induce LEC‐1 apoptosis were higher than those used previously in other cells, including hepatocytes, suggesting that LEC‐1 are highly resistant to the Fas apoptotic pathway. TNF treatment of LEC‐1 induced up‐regulation of Fas receptor on these cells. In contrast, TNF did not induce the expression of FasL on LEC‐1. An increased susceptibility to Fas‐mediated apoptosis was observed in TNF‐treated LEC‐1. Enhanced susceptibility to Fas‐mediated apoptosis was also observed in LEC‐1 pretreated with actinomycin D, suggesting that transcription of message coding for protective proteins is necessary to protect these cells against Fas‐mediated apoptosis. Up‐regulation of VCAM‐1 and ICAM‐1 was observed in LEC‐1 treated with a dose of Fas agonist that does not induce apoptosis. To our knowledge, this is the first report that Fas mediates apoptosis in LEC, suggesting that apoptosis of these cells may participate in the liver damage observed in animals after receiving anti‐Fas mAb or soluble FasL. Our findings also suggest that the Fas/FasL system may transduce activating signals independently of cell death in LEC‐1.—Cardier, J. E., Schulte, T., Kammer, H., Kwak, J., Cardier, M. Fas (CD95, APO‐1) antigen expression and function in murine liver endothelial cells: implications for the regulation of apoptosis in liver endothelial cells. FASEB J. 13, 1950–1960 (1999)</description><identifier>ISSN: 0892-6638</identifier><identifier>EISSN: 1530-6860</identifier><identifier>DOI: 10.1096/fasebj.13.14.1950</identifier><identifier>PMID: 10544178</identifier><language>eng</language><publisher>United States: Federation of American Societies for Experimental Biology</publisher><subject>actinomycin D ; Animals ; APO-1 protein ; Apoptosis ; CD95 antigen ; Endothelium, Vascular - cytology ; Fas Ligand Protein ; fas Receptor - analysis ; fas Receptor - physiology ; Fas‐L ; HUVEC ; Intercellular Adhesion Molecule-1 - biosynthesis ; Intercellular cell adhesion molecule 1 ; LEC‐1 ; liver ; Liver - cytology ; Membrane Glycoproteins - analysis ; Mice ; Tumor Necrosis Factor-alpha - pharmacology ; Vascular cell adhesion molecule 1 ; Vascular Cell Adhesion Molecule-1 - biosynthesis</subject><ispartof>The FASEB journal, 1999-11, Vol.13 (14), p.1950-1960</ispartof><rights>FASEB</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4840-bea84beeee5c1cad89ab4149c3599727977e066a4d322150894873f9f3229ebc3</citedby><cites>FETCH-LOGICAL-c4840-bea84beeee5c1cad89ab4149c3599727977e066a4d322150894873f9f3229ebc3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1096%2Ffasebj.13.14.1950$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1096%2Ffasebj.13.14.1950$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27903,27904,45553,45554</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10544178$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cardier, Jose E.</creatorcontrib><creatorcontrib>Schulte, Tara</creatorcontrib><creatorcontrib>Kammer, Heide</creatorcontrib><creatorcontrib>Kwak, Jenny</creatorcontrib><creatorcontrib>Cardier, Marisabel</creatorcontrib><title>Fas (CD95, APO‐1) antigen expression and function in murine liver endothelial cells: implications for the regulation of apoptosis in liver endothelial cells</title><title>The FASEB journal</title><addtitle>FASEB J</addtitle><description>ABSTRACTThe Fas (CD95, APO‐1) receptor is a membrane‐associated polypeptide that can mediate apoptosis in various cell types. Although Fas receptor is expressed in endothelial cells (EC), little is known about its function in these cells. The expression of Fas by liver endothelial cells (LEC) suggests that upon stimulation, apoptosis may occur in these cells. We show that Fas is highly and constitutively expressed in cloned murine liver endothelial cells (LEC‐1). In contrast, FasL expression was not detected at the protein and mRNA level in these cells. Our results show that Fas ligation in LEC‐1 induces apoptotic cell death, indicating that Fas receptor is functional in these cells. The doses of Fas agonist required to induce LEC‐1 apoptosis were higher than those used previously in other cells, including hepatocytes, suggesting that LEC‐1 are highly resistant to the Fas apoptotic pathway. TNF treatment of LEC‐1 induced up‐regulation of Fas receptor on these cells. In contrast, TNF did not induce the expression of FasL on LEC‐1. An increased susceptibility to Fas‐mediated apoptosis was observed in TNF‐treated LEC‐1. Enhanced susceptibility to Fas‐mediated apoptosis was also observed in LEC‐1 pretreated with actinomycin D, suggesting that transcription of message coding for protective proteins is necessary to protect these cells against Fas‐mediated apoptosis. Up‐regulation of VCAM‐1 and ICAM‐1 was observed in LEC‐1 treated with a dose of Fas agonist that does not induce apoptosis. To our knowledge, this is the first report that Fas mediates apoptosis in LEC, suggesting that apoptosis of these cells may participate in the liver damage observed in animals after receiving anti‐Fas mAb or soluble FasL. Our findings also suggest that the Fas/FasL system may transduce activating signals independently of cell death in LEC‐1.—Cardier, J. E., Schulte, T., Kammer, H., Kwak, J., Cardier, M. Fas (CD95, APO‐1) antigen expression and function in murine liver endothelial cells: implications for the regulation of apoptosis in liver endothelial cells. FASEB J. 13, 1950–1960 (1999)</description><subject>actinomycin D</subject><subject>Animals</subject><subject>APO-1 protein</subject><subject>Apoptosis</subject><subject>CD95 antigen</subject><subject>Endothelium, Vascular - cytology</subject><subject>Fas Ligand Protein</subject><subject>fas Receptor - analysis</subject><subject>fas Receptor - physiology</subject><subject>Fas‐L</subject><subject>HUVEC</subject><subject>Intercellular Adhesion Molecule-1 - biosynthesis</subject><subject>Intercellular cell adhesion molecule 1</subject><subject>LEC‐1</subject><subject>liver</subject><subject>Liver - cytology</subject><subject>Membrane Glycoproteins - analysis</subject><subject>Mice</subject><subject>Tumor Necrosis Factor-alpha - pharmacology</subject><subject>Vascular cell adhesion molecule 1</subject><subject>Vascular Cell Adhesion Molecule-1 - biosynthesis</subject><issn>0892-6638</issn><issn>1530-6860</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkUFu1TAQhi0Eoo_CAdggrxBIzcMTO07M7vXRR4sqFamwtpxkUlw5cWonQHccgRP0cD1Jk6YLNqjeWDP-5rPln5DXwNbAlPzQmIjl5Rr4GsQaVMaekBVknCWykOwpWbFCpYmUvNgjL2K8ZIwBA_mc7AHLhIC8WJGbnYn03faTyg7o5uvZ7Z-_8J6abrAX2FH83QeM0fpuatW0GbtqmAvb0XYMtkPq7E8MFLvaDz_QWeNohc7Fj9S2vbOVmfFIGx_odE4DXozuvkd9Q03v-8FHG2fff0QvybPGuIivHvZ98n139G17nJyefT7Zbk6TShSCJSWaQpQ4rayCytSFMqUAoSqeKZWnucpzZFIaUfM0hWz6F1HkvFHNVCosK75P3i7ePvirEeOgWxvnF5gO_Ri1VCnPihweBSEXaS6UnEBYwCr4GAM2ug-2NeFaA9NzenpJTwPXIPSc3jTz5kE-li3W_0wscU3AZgF-WYfXjxv17vww3W3Ojw6_AAdxf8kd18mtTw</recordid><startdate>199911</startdate><enddate>199911</enddate><creator>Cardier, Jose E.</creator><creator>Schulte, Tara</creator><creator>Kammer, Heide</creator><creator>Kwak, Jenny</creator><creator>Cardier, Marisabel</creator><general>Federation of American Societies for Experimental Biology</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TM</scope><scope>7X8</scope></search><sort><creationdate>199911</creationdate><title>Fas (CD95, APO‐1) antigen expression and function in murine liver endothelial cells: implications for the regulation of apoptosis in liver endothelial cells</title><author>Cardier, Jose E. ; Schulte, Tara ; Kammer, Heide ; Kwak, Jenny ; Cardier, Marisabel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4840-bea84beeee5c1cad89ab4149c3599727977e066a4d322150894873f9f3229ebc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>actinomycin D</topic><topic>Animals</topic><topic>APO-1 protein</topic><topic>Apoptosis</topic><topic>CD95 antigen</topic><topic>Endothelium, Vascular - cytology</topic><topic>Fas Ligand Protein</topic><topic>fas Receptor - analysis</topic><topic>fas Receptor - physiology</topic><topic>Fas‐L</topic><topic>HUVEC</topic><topic>Intercellular Adhesion Molecule-1 - biosynthesis</topic><topic>Intercellular cell adhesion molecule 1</topic><topic>LEC‐1</topic><topic>liver</topic><topic>Liver - cytology</topic><topic>Membrane Glycoproteins - analysis</topic><topic>Mice</topic><topic>Tumor Necrosis Factor-alpha - pharmacology</topic><topic>Vascular cell adhesion molecule 1</topic><topic>Vascular Cell Adhesion Molecule-1 - biosynthesis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cardier, Jose E.</creatorcontrib><creatorcontrib>Schulte, Tara</creatorcontrib><creatorcontrib>Kammer, Heide</creatorcontrib><creatorcontrib>Kwak, Jenny</creatorcontrib><creatorcontrib>Cardier, Marisabel</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Nucleic Acids Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>The FASEB journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cardier, Jose E.</au><au>Schulte, Tara</au><au>Kammer, Heide</au><au>Kwak, Jenny</au><au>Cardier, Marisabel</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Fas (CD95, APO‐1) antigen expression and function in murine liver endothelial cells: implications for the regulation of apoptosis in liver endothelial cells</atitle><jtitle>The FASEB journal</jtitle><addtitle>FASEB J</addtitle><date>1999-11</date><risdate>1999</risdate><volume>13</volume><issue>14</issue><spage>1950</spage><epage>1960</epage><pages>1950-1960</pages><issn>0892-6638</issn><eissn>1530-6860</eissn><abstract>ABSTRACTThe Fas (CD95, APO‐1) receptor is a membrane‐associated polypeptide that can mediate apoptosis in various cell types. Although Fas receptor is expressed in endothelial cells (EC), little is known about its function in these cells. The expression of Fas by liver endothelial cells (LEC) suggests that upon stimulation, apoptosis may occur in these cells. We show that Fas is highly and constitutively expressed in cloned murine liver endothelial cells (LEC‐1). In contrast, FasL expression was not detected at the protein and mRNA level in these cells. Our results show that Fas ligation in LEC‐1 induces apoptotic cell death, indicating that Fas receptor is functional in these cells. The doses of Fas agonist required to induce LEC‐1 apoptosis were higher than those used previously in other cells, including hepatocytes, suggesting that LEC‐1 are highly resistant to the Fas apoptotic pathway. TNF treatment of LEC‐1 induced up‐regulation of Fas receptor on these cells. In contrast, TNF did not induce the expression of FasL on LEC‐1. An increased susceptibility to Fas‐mediated apoptosis was observed in TNF‐treated LEC‐1. Enhanced susceptibility to Fas‐mediated apoptosis was also observed in LEC‐1 pretreated with actinomycin D, suggesting that transcription of message coding for protective proteins is necessary to protect these cells against Fas‐mediated apoptosis. Up‐regulation of VCAM‐1 and ICAM‐1 was observed in LEC‐1 treated with a dose of Fas agonist that does not induce apoptosis. To our knowledge, this is the first report that Fas mediates apoptosis in LEC, suggesting that apoptosis of these cells may participate in the liver damage observed in animals after receiving anti‐Fas mAb or soluble FasL. Our findings also suggest that the Fas/FasL system may transduce activating signals independently of cell death in LEC‐1.—Cardier, J. E., Schulte, T., Kammer, H., Kwak, J., Cardier, M. Fas (CD95, APO‐1) antigen expression and function in murine liver endothelial cells: implications for the regulation of apoptosis in liver endothelial cells. FASEB J. 13, 1950–1960 (1999)</abstract><cop>United States</cop><pub>Federation of American Societies for Experimental Biology</pub><pmid>10544178</pmid><doi>10.1096/fasebj.13.14.1950</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0892-6638
ispartof The FASEB journal, 1999-11, Vol.13 (14), p.1950-1960
issn 0892-6638
1530-6860
language eng
recordid cdi_proquest_miscellaneous_69235871
source MEDLINE; Wiley Online Library Journals Frontfile Complete; Alma/SFX Local Collection
subjects actinomycin D
Animals
APO-1 protein
Apoptosis
CD95 antigen
Endothelium, Vascular - cytology
Fas Ligand Protein
fas Receptor - analysis
fas Receptor - physiology
Fas‐L
HUVEC
Intercellular Adhesion Molecule-1 - biosynthesis
Intercellular cell adhesion molecule 1
LEC‐1
liver
Liver - cytology
Membrane Glycoproteins - analysis
Mice
Tumor Necrosis Factor-alpha - pharmacology
Vascular cell adhesion molecule 1
Vascular Cell Adhesion Molecule-1 - biosynthesis
title Fas (CD95, APO‐1) antigen expression and function in murine liver endothelial cells: implications for the regulation of apoptosis in liver endothelial cells
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T18%3A56%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Fas%20(CD95,%20APO%E2%80%901)%20antigen%20expression%20and%20function%20in%20murine%20liver%20endothelial%20cells:%20implications%20for%20the%20regulation%20of%20apoptosis%20in%20liver%20endothelial%20cells&rft.jtitle=The%20FASEB%20journal&rft.au=Cardier,%20Jose%20E.&rft.date=1999-11&rft.volume=13&rft.issue=14&rft.spage=1950&rft.epage=1960&rft.pages=1950-1960&rft.issn=0892-6638&rft.eissn=1530-6860&rft_id=info:doi/10.1096/fasebj.13.14.1950&rft_dat=%3Cproquest_cross%3E17427496%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17427496&rft_id=info:pmid/10544178&rfr_iscdi=true